Sterile Pharmaceutical Supply – Water for Injection

The contract pertains to the supply of sterile Water for Injection, USP, in 20mL flip-top vials, with each case containing 25 units, fully compliant with United States Pharmacopeia standards for use in injectable medical applications. The product must meet stringent pharmaceutical requirements to ensure safety and efficacy for clinical use, and packaging must maintain sterility and integrity throughout distribution and storage. The solicitation is issued as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance designated to occur at APO, ZIP 09855, indicating the requirement supports military medical operations. The solicitation was posted on July 23, 2026, with a response deadline of July 29, 2026, leaving a six-day window for submissions. The NAICS code 325412 identifies this as a pharmaceutical preparation manufacturing activity, underscoring the technical and regulatory rigor expected from suppliers. There is no set-aside designation listed, meaning all eligible contractors may bid, and the procurement is conducted through the DLA DIBBS platform, with the official solicitation accessible via the provided URL. Suppliers must ensure full compliance with USP guidelines, proper labeling, and reliable logistics to meet the needs of military medical facilities.